News Between Reporter

The drug sample that was recently tested contained a dangerous cocktail of substances, including multiple nitazenes, fentanyl analogues, xylazine, diphenhydramine, caffeine, and medetomidine. The mention of medetomidine in particular caught my attention, as it has been linked to a recent surge in overdoses. While opioid overdoses are unfortunately nothing new to me, this particular case
Autism spectrum disorder is a complex neurological condition that manifests in a variety of ways. Some individuals may experience milder symptoms, while others face significant challenges with social, language, and cognitive skills. For those with more ‘profound’ cases of autism, lifelong supportive care may be necessary. Understanding the biological foundations behind this disparity in autism
Roy Herbst, MD, PhD, of Yale Cancer Center, recently discussed groundbreaking new data surrounding osimertinib (Tagrisso) in patients with EGFR-mutated non-small cell lung cancer (NSCLC). The LAURA and ADAURA trials have provided exciting insights into the potential of osimertinib in improving progression-free survival for patients with stage III NSCLC. The findings from the ADAURA trial